Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

mAcademia - Science, More than Just Academia.

Claim This Podcast

by Elena Itskovich & Ofer Yizhar Barnea

5.0(8 reviews)

53 episodes

Updated Daily

Accepts GuestsHas Sponsors

Podcast Overview

After spending time in academia and exploring the unknown, the industry often seems too limited scientifically to those finishing a PhD. We will explore the bridge between the industry and academia to understand how basic scientific findings take shape into products and strategies. We will also follow the career paths of researchers who are in academia or outside of it, professionals that made their choice, followed it through and come to us to tell all about it. Academia or not? And if not, what else? That is a tough nut to crack. Call us the nutcrackers.

Language

🇺🇲

Publishing Since

4/24/2020

Visit Website View on Apple Podcasts RSS Feed

1 verified contact email on file for mAcademia - Science, More than Just Academia.

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

January 25, 2023

#52 - Designing a career - with Evan Bai from Vertex Pharmaceuticals

Dr. Evan Bai is computational genomic team leader at Vertex Pharmaceuticals. There he leads collaborations across Research, Clinical, and Commercial. By designing and analyzing genomic studies across the drug discovery pipeline, ranging from target discovery to defining treatable patient population, he contributed to the advancement of one disease program from compound screening into Phase II clinical trials, and other disease programs from target discovery into lead optimization. Evan is also the founder of Hanwen Interiors, an interior decorating firm specializing in modern, Asian-inspired homes. He helps homeowners find peace and retreat by creating functional and beautiful designs. Hanwen Interiors is also a proud member of the Massachusetts LGBT Chamber of Commerce. To help support the LGBTQ+ community, I pledge to donate 10% of our design fees to local LGBTQ+ non-profit organizations. Evan is also the volunteer leader and co-chair of Vertex Pharmaceuticals’ PRIDE Employee Resource Group (with over 400 members globally), where he leads and oversees company-wide programs that support the career advancement of LGBTQ+ employees and allies. Elena talked with Evan about his career path to and at Vertex, his new role as interior designer and the parallels between the two. They also discussed how being part of the LGBTQ+ community has affected his career and how he is serving and supporting this community now. You can find more about Evan: Website: hanwen-interiors.com Instagram handle: @hanwen.interiors LinkedIn profile: https://www.linkedin.com/in/evan-bai/ Music credits Funkorama Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0/

November 17, 2022

#51 - Science is exciting no matter where you do it - with Yaniv Erlich from Eleven Therapeutics

Dr. Yaniv Erlich is the co-founder and CEO of Eleven Therapeutics. Prior, he was the CSO of MyHeritage, a consumer genomics company (acquired by Francisco Partners), an Associate Professor of Computer Science at Columbia University and a Principal Investigator at the Whitehead Institute, MIT.  We talked with Yaniv about his unique career that led him to leave academia and focus his efforts on building exciting biotech companies. Yaniv shared his insights into academic and non academic career development pathways for scientists, delved into the advantages of building a company in the UK as well as shed some light on how research is done at Eleven Therapeutics.  Tune in and join the discussion in our 'mAcademia podcast' group on Facebook.  Music Funkorama Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0/

October 11, 2022

#50 - Finding new paths paved with proteomics - with Gali Arad and Eran Seger from Protai

Gali Arad and Eran Seger from Protai had talked to us about moving from their previous life in tech and academia into the fast pace of illuminating the druggable Proteome for better cures. Eran Seger is the Co-Founder and CEO of Protai, a fast-growing biotech startup sitting on the intersection of proteomics and machine learning to develop novel therapeutics for a variety of complex diseases. Eran is an experienced technology executive and entrepreneur with a strong technical background and over 15 years of tech leadership positions at the Israeli Intelligence forces and HighTech. Gali Arad, PhD is a Computational Biologist and the first employee of Protai, a drug discovery startup combining AI and proteomics to create intelligence-driven pharma. She is an end-to-end computational biology scientist, with broad experience in systems biology, data analysis, hands-on technological practice, and clinical samples handling. In her current role, Gali leads the scientific research, focused on target discovery and prioritization, and the collection and curation of Protai’s data warehouse. She holds a Ph.D from Tel Aviv University, applying mass-spectrometry-based proteomics to study cancer heterogeneity. Her findings were published in top-tier scientific journals and emphasized the added value of clinical proteomics in the study of cancer. Music: Funkorama Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0/

53 total episodes available

Deep-dive analytics for mAcademia - Science, More than Just Academia.

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is mAcademia - Science, More than Just Academia.?: After spending time in academia and exploring the unknown, the industry often seems too limited scientifically to those finishing a PhD. We will explore the bridge between the industry and academia to understand how basic scientific findings take shape into products and strategies. We will also follow the career paths of researchers who are in academia or outside of it, professionals that made their choice, followed it through and come to us to tell all about it.

Academia or not? And if not, what else? That is a tough nut to crack. Call us the nutcrackers.
How often does this podcast release new episodes?: This podcast updates daily.
Where can I listen to this podcast?: This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.